1 / 10

How to make a good economics submission to SMC

How to make a good economics submission to SMC. Dr Andrew Walker. How NDC reviewers make their decisions What are the common problems to avoid in your submissions Potential ways to improve submission quality. Reviewing the economics in a submission.

garry
Télécharger la présentation

How to make a good economics submission to SMC

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. How to make a good economics submission to SMC Dr Andrew Walker

  2. How NDC reviewers make their decisions • What are the common problems to avoid in your submissions • Potential ways to improve submission quality

  3. Reviewing the economics in a submission • Checklist used to structure critical appraisal exercise • No limit on the number of ‘accepted for use’ decisions we make

  4. Things we look for at NDC stage the deal-breakers • Does it have any economics? • Is there an obvious ‘fatal flaw’? • Is the ICER very high?

  5. If no deal-breakers, what next? • If no ‘fatal flaw’ or very high ICER, what other problems are there? • How material are they? • Does sensitivity analysis help with any optimism bias?

  6. Most common problems 1 • Over-optimistic assumptions • Issues with comparator • Clinical data weaknesses

  7. Most common problems 2 • Issues with time horizon • Issues with indirect comparison • Generalisability of data inputs

  8. Most common problems 3 • Lack of transparency • Errors • Failure to consider other possible role for medicine

  9. Potential ways to improve quality? • Use more sensitivity analysis • but might take time • what if ICER already high? • company may chose not to provide analysis to address issue raised in draft DAD

  10. Another potential solution? • SMC to provide more education to companies • Is there a need to help small companies? • At what level would the education be most effective?

More Related